COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
USA - NYSE:CHCT - US20369C1062 - REIT
13.93 USD
+0.37 (+2.73%)
13.93 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to CHCT. CHCT was compared to 129 industry peers in the Diversified REITs industry. CHCT may be in some trouble as it scores bad on both profitability and health. CHCT is valied quite expensively at the moment, while it does show a decent growth rate. CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT has reported negative net income.
In the past year CHCT had a positive cash flow from operations.
CHCT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CHCT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CHCT (-1.08%) is worse than 65.12% of its industry peers.
CHCT has a Return On Equity of -2.37%. This is in the lower half of the industry: CHCT underperforms 63.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.16%, CHCT is in line with its industry, outperforming 41.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHCT is in line with the industry average of 3.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.08% | ||
| ROE | -2.37% | ||
| ROIC | 2.16% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
1.3 Margins
CHCT has a Operating Margin (22.02%) which is comparable to the rest of the industry.
CHCT's Operating Margin has declined in the last couple of years.
CHCT has a better Gross Margin (80.40%) than 81.40% of its industry peers.
CHCT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.02% | ||
| PM (TTM) | N/A | ||
| GM | 80.4% |
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHCT is destroying value.
CHCT has more shares outstanding than it did 1 year ago.
CHCT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CHCT is higher compared to a year ago.
2.2 Solvency
CHCT has an Altman-Z score of 0.75. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
CHCT has a Altman-Z score of 0.75. This is in the better half of the industry: CHCT outperforms 67.44% of its industry peers.
The Debt to FCF ratio of CHCT is 41.17, which is on the high side as it means it would take CHCT, 41.17 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 41.17, CHCT is doing good in the industry, outperforming 68.22% of the companies in the same industry.
A Debt/Equity ratio of 1.15 is on the high side and indicates that CHCT has dependencies on debt financing.
CHCT's Debt to Equity ratio of 1.15 is in line compared to the rest of the industry. CHCT outperforms 54.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 41.17 | ||
| Altman-Z | 0.75 |
ROIC/WACC0.33
WACC6.65%
2.3 Liquidity
CHCT has a Current Ratio of 0.59. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.59, CHCT is not doing good in the industry: 75.19% of the companies in the same industry are doing better.
A Quick Ratio of 0.28 indicates that CHCT may have some problems paying its short term obligations.
With a Quick ratio value of 0.28, CHCT is not doing good in the industry: 87.60% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.28 |
3. Growth
3.1 Past
The earnings per share for CHCT have decreased strongly by -135.90% in the last year.
Measured over the past years, CHCT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.22% on average per year.
CHCT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.01%.
Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 13.73% on average per year.
EPS 1Y (TTM)-135.9%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-1350%
Revenue 1Y (TTM)-18.01%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%9.49%
3.2 Future
Based on estimates for the next years, CHCT will show a very strong growth in Earnings Per Share. The EPS will grow by 37.91% on average per year.
The Revenue is expected to grow by 9.17% on average over the next years. This is quite good.
EPS Next Y-216.57%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
EPS Next 5YN/A
Revenue Next Year4.5%
Revenue Next 2Y5.28%
Revenue Next 3Y6.02%
Revenue Next 5Y9.17%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHCT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 30.35, which means the current valuation is very expensive for CHCT.
76.74% of the companies in the same industry are more expensive than CHCT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, CHCT is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 30.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHCT is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHCT indicates a somewhat cheap valuation: CHCT is cheaper than 70.54% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.33 | ||
| EV/EBITDA | 12.7 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 37.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.84%
EPS Next 3Y37.91%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 13.74%, CHCT is a good candidate for dividend investing.
CHCT's Dividend Yield is rather good when compared to the industry average which is at 7.01. CHCT pays more dividend than 93.80% of the companies in the same industry.
CHCT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 13.74% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.99%.
CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
The earnings of CHCT are negative and hence is the payout ratio. CHCT will probably not be able to sustain this dividend level.
The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-508.87%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
13.93
+0.37 (+2.73%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners84.9%
Inst Owner Change0%
Ins Owners5.9%
Ins Owner Change7.27%
Market Cap395.19M
Analysts81.82
Price Target19.48 (39.84%)
Short Float %3.26%
Short Ratio3.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 13.74% |
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-508.87%
Div Incr Years9
Div Non Decr Years9
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-73.26%
Min EPS beat(2)-88.54%
Max EPS beat(2)-57.98%
EPS beat(4)0
Avg EPS beat(4)-58.62%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-52.43%
EPS beat(12)1
Avg EPS beat(12)-56.5%
EPS beat(16)1
Avg EPS beat(16)-45.99%
Revenue beat(2)0
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.52%
Revenue beat(4)0
Avg Revenue beat(4)-2.06%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.52%
Revenue beat(8)0
Avg Revenue beat(8)-3.6%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)2
Avg Revenue beat(16)-2.63%
PT rev (1m)0%
PT rev (3m)-6.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-340%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 30.35 | ||
| P/S | 3.35 | ||
| P/FCF | 32.33 | ||
| P/OCF | 6.85 | ||
| P/B | 0.9 | ||
| P/tB | 0.91 | ||
| EV/EBITDA | 12.7 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.46
Fwd EY3.3%
FCF(TTM)0.43
FCFY3.09%
OCF(TTM)2.03
OCFY14.6%
SpS4.16
BVpS15.43
TBVpS15.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.08% | ||
| ROE | -2.37% | ||
| ROCE | 2.74% | ||
| ROIC | 2.16% | ||
| ROICexc | 2.18% | ||
| ROICexgc | 2.21% | ||
| OM | 22.02% | ||
| PM (TTM) | N/A | ||
| GM | 80.4% | ||
| FCFM | 10.35% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexcg growth 3Y-9.66%
ROICexcg growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 41.17 | ||
| Debt/EBITDA | 7.24 | ||
| Cap/Depr | 104.47% | ||
| Cap/Sales | 38.52% | ||
| Interest Coverage | 1.05 | ||
| Cash Conversion | 82.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.28 | ||
| Altman-Z | 0.75 |
F-Score3
WACC6.65%
ROIC/WACC0.33
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.9%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-1350%
EPS Next Y-216.57%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.01%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%9.49%
Revenue Next Year4.5%
Revenue Next 2Y5.28%
Revenue Next 3Y6.02%
Revenue Next 5Y9.17%
EBIT growth 1Y-37.86%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year263.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.01%
OCF growth 3Y1.48%
OCF growth 5Y12.72%